Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-18

FDA Approved: ANASTROZOLE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for a generic version of anastrozole from Zydus Lifesciences Limited. The approval allows marketing in the United States…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)

Snippet

SUPPL AP for ANASTROZOLE (ANASTROZOLE)